Amends the Homeland Security Act to enhance drug detection capabilities using AI, requiring research and development of equipment for law enforcement. Directs adherence to AI risk management guidelines and prioritization based on DEA threat reports.
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a binding federal statute passed by the U.S. House of Representatives that amends the Homeland Security Act of 2002, creating mandatory legal obligations for the Under Secretary for Science and Technology with enforceable requirements.
The document has minimal coverage of AI risk domains, with limited focus on AI system security (2.2) and governance (6.5). The primary focus is on drug detection equipment development rather than comprehensive AI risk management. Coverage is concentrated in technical system requirements and regulatory compliance rather than broader AI safety concerns.
The document primarily governs the Public Administration excluding National Security sector by directing federal agencies (DHS, DEA) to develop AI-enhanced drug detection capabilities. It also has secondary coverage of Scientific Research and Development Services through mandated R&D activities, and minimal coverage of Information sector through AI/ML technology development requirements.
The document primarily covers the Plan and Design, Build and Use Model, and Verify and Validate stages of the AI lifecycle. It mandates research and development of AI-enhanced drug detection technologies, requires adherence to NIST AI Risk Management Framework, and emphasizes testing and evaluation of equipment effectiveness and safety.
The document explicitly mentions artificial intelligence and machine learning technologies for drug detection. It references AI as defined in the National Artificial Intelligence Initiative Act and requires adherence to NIST AI Risk Management Framework. The focus is on task-specific AI applications for controlled substance detection rather than general-purpose or frontier AI systems.
United States House of Representatives
The document was passed by the House of Representatives on September 9, 2024, indicating this legislative body proposed and approved the Act.
Department of Homeland Security; Under Secretary for Science and Technology
The Department of Homeland Security, through the Under Secretary for Science and Technology, has authority to implement and oversee compliance with the Act's requirements as part of the amended Homeland Security Act.
Drug Enforcement Administration; National Institute of Standards and Technology
The DEA provides threat assessment information to guide priorities, and NIST provides the AI Risk Management Framework that must be followed, suggesting both have monitoring and guidance roles.
Under Secretary for Science and Technology; Directorate of Science and Technology; Department of Homeland Security
The Act specifically targets the Under Secretary for Science and Technology and the Directorate of Science and Technology within DHS, requiring them to conduct research and development on AI-enhanced drug detection equipment.
3 subdomains (3 Minimal)